In-Liquid Plasma Process for Size- and Shape-Controlled Synthesis of Silver Nanoparticles by Controlling Gas Bubbles in Water.

Most methods controlling size and shape of metal nanoparticles are chemical methods, and little work has been done using only plasma methods. Size- and shape-controlled synthesis of silver nanoparticles (Ag NPs) is proposed based on adjusting the gas bubble formation produced between two silver electrodes. The application of a voltage waveform with three different pulse widths during a plasma process in water can generate different gas bubble formations. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) images of Ag NPs synthesized using three different bubble formations reveal that spherical Ag NPs are synthesized when very tiny bubbles are generated between two electrodes or when only the grounded electrode is enveloped with large gas bubbles, but Ag nanoplates are synthesized when both electrodes are completely enveloped with large gas bubbles.

Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells.

Microvesicles (MVs) released by cells are involved in a multitude of physiological events as important mediators of intercellular communication. MVs derived from mesenchymal stem cells (MSCs) contain various paracrine factors from the cells that primarily contribute to their therapeutic efficacy observed in numerous clinical trials. As nano-sized and bi-lipid layered vesicles retaining therapeutic potency equivalent to that of MSCs, MSC-derived MVs have been in focus as ideal medicinal candidates for regenerative medicine, and are preferred over MSC infusion therapy with their improved safety profiles. However, technical challenges in obtaining sufficient amounts of MVs have limited further progress in studies and clinical application. Of the multiple efforts to reinforce the therapeutic capacity of MSCs, few studies have reportedly examined the scale-up of MSC-derived MV production. In this study, we successfully amplified MV secretion from MSCs compared to the conventional culture method using a simple and efficient 3D-bioprocessing method. The MSC-derived MVs produced in our dynamic 3D-culture contained numerous therapeutic factors such as cytokines and micro-RNAs, and showed their therapeutic potency in in vitro efficacy evaluation. Our results may facilitate diverse applications of MSC-derived MVs from the bench to the bedside, which requires the large-scale production of MVs.

Effects of MgO Nanocrystal Powder on Long-Term Sustain and Address Discharge Characteristics in ac-Plasma Display Panel.

We investigated the characteristics of MgO surface with MgO nanocrystal powders due to the longterm (500 hours) ion bombardment comparing with the conventional MgO surface in this study. When the MgO nanocrystal powders were coated on the conventional MgO surface, it was observed that the sputtered Mg particles from MgO surface were re-deposited on the MgO nanocrystal powders, which was able to significantly suppress the re-crystallization on the phosphor layers. We confirm that the MgO nanocrystal powders play a significant role in suppressing the degradation of the MgO surface and phosphor layer after long-term severe ion bombardments. Accordingly, when the MgO nanocrystal powers were applied to the conventional MgO surface, the variations of discharge characteristics, such as address discharge delay time, firing voltage of sustain and address discharge, and luminance, were significantly reduced comparing with the conventional MgO surface.

Manufacturing Method for Core-Shell Metal Nanoparticle Structure Having Excellent Oxidation Stability Using Cu@Ag Core-Shell Nanoparticles.

As the development of manufacturing technology for electronic devices, propresses it is necessary to study manufacturing technologies for mass storage, low-volume, improved reliability, and low cost materials for electronic devices used in data communication. The noble metals are the most commonly used raw materials used in such manufacturing. However, the raw materials (Ag, Pt, etc.) are expensive and raise the manufacturing cost. So, there is a need to replace these materials with raw materials of low cost. Recently, the much-cheaper Cu has received attention in that it has the same properties as the noble metals. Cu has good physical and chemical properties. However, its anti-oxidation is weak. Therefore, to make up for this weak point, research has generally been conducted to find a method to coat copper with a noble metal. The coating, comprised of the noble metal, is strong against the oxidation of the Cu surface. In this study, we made Cu@Ag core-shell nanoparticles; these particles have the same level of electro-conductivity as Ag. These materials are expected to reduce the product cost of raw materials.

Heparin conjugated polylactide as a blood compatible material.

A heparin-conjugated biodegradable polymer (PLA-heparin) by the direct coupling of heparin to polylactide (PLA) was synthesized and characterized. The surface exposed heparin content associated PLA-heparin was measured to be 0.067 microg/cm2. PLA-heparin coated surface has shown higher hydrophilicity rather than control PLA surface. The clotting time of PLA-heparin conjugate measured by activated partial thromboplastin time (APTT) was significantly prolonged as compared to PLA. The bioactivity of bound heparin measured by APTT corresponds to 17.4% of free heparin. It has been also demonstrated that the conjugation of heparin suppresses the protein adsorption as well as the platelet adhesion. These results indicate that the unique property of bound heparin has an inhibiting influence on the coagulation, plasma protein adsorption, and subsequent platelet adhesion systems. This novel PLA-heparin conjugate could be applied as blood/tissue compatible biodegradable materials for implantable medical devices and tissue engineering.

In vitro biocompatibility assessment of sulfonated polyrotaxane-immobilized polyurethane surfaces.

Sulfonated polyrotaxanes (PRx-SO(3)'s), in which sulfonated alpha-cyclodextrins (alpha-CDs) were threaded onto the poly(ethylene glycol) (PEG) segments in a PEG-b-poly(propylene glycol) (PPG)-b-PEG triblock copolymer (Pluronic) capped with benzyloxycarbonyl (Z)-L-phenylalanine (Z-L-Phe), were prepared as a novel surface-modifying biomaterial. Surface modification of the polyurethane (PU) was carried out by blending the PRx-SO(3)'s with a PU solution, followed by solution casting. The incorporated PRx-SO(3)'s led to the enhanced hydrophilicity by changing the surface properties of the PU matrix. Modified PUs showed the stable entrapment of the PRx-SO(3)'s with little extraction into water and enhanced mechanical properties after exposure to water compared to the PU control. The incorporated PRx-SO(3)'s repelled the proteins and kept them from closely approaching the surface areas, prevented platelet activation by thrombin, and effectively repelled bacteria. These results suggest that both the supramolecular structure of the polyrotaxanes and exposure of the sulfonated groups onto the surfaces contribute to these phenomena. Thus, surface modification with PRx-SO(3)'s is suggested to be useful for the fabrication of biocompatible medical devices.

Anticoagulant activity of sulfonated polyrotaxanes as blood-compatible materials.

Polyrotaxanes, in which alpha-cyclodextrins (alpha-CDs) are threaded onto poly(ethylene glycol)-b-poly(propylene glycol)-b-poly(ethylene glycol) triblock copolymers (Pluronic) capped with benzyloxycarbonyl(Z)-L-phenylalanine (Z-L-Phe), were prepared, and sulfopropyl groups were introduced to hydroxyl groups of alpha-CDs in the polyrotaxanes. The supramolecular structure and the chemical composition of the polyrotaxanes after the sulfonation were confirmed by 1H-NMR, 13C-NMR, and elemental analysis. Anticoagulant activity of the polyrotaxanes and sulfonated polyrotaxanes was measured by activated partial thromboplastin time (APTT). It was found that the polyrotaxanes and the sulfonated polyrotaxanes showed greater anticoagulant activity than Pluronic itself, suggesting that both the supramolecular structure of the polyrotaxanes and the sulfonated groups contribute to the inhibition of intrinsic coagulation factors. Finally, our designed polyrotaxanes are suggested to be a promising candidate when fabricating blood-compatible medical devices by blending with or coating on clinically used polymers.